QuidelOrtho Gets FDA Clearance for Multiplex Molecular Platform and Herpes Simplex Virus Assay
QuidelOrtho received 510(K) clearance from the FDA for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test
Read MorePosted by Andy Lundin | Dec 21, 2023 | Molecular Diagnostics, Sexually Transmitted Diseases |
QuidelOrtho received 510(K) clearance from the FDA for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test
Read MorePosted by Andy Lundin | Dec 19, 2023 | Urinalysis & Toxicology |
The new panel from Quest tests for 88 compounds, and covers a broad array of drug classes, and other illicit additives.
Read MorePosted by Andy Lundin | Dec 11, 2023 | Diagnostic Technologies |
Researchers developed new lab-on-a-chip diagnostic technology that has the potential to make on-the-spot tests widely accessible.
Read MorePosted by Andy Lundin | Dec 7, 2023 | Hematology Instrumentation |
The hematology analyzer provides patient-side results to screen for conditions including infection, leukemia, and other blood-related cancers.
Read MorePosted by Chris Wolski | Nov 24, 2023 | Tuberculosis |
Though without a standard TB diagnosis, guidelines recommend the use of either the TST or IGRAs to test for latent tuberculosis infections.
Read More